Dolby Laboratories Inc

For the period ended Mar 28, 2025. Filed May 1, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 28, 2025 · Filed May 1, 2025

DLB$64.67-0.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Unaudited Interim Condensed Consolidated Balance Sheets

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

	March 28,2025	September 27,2024
ASSETS
Current assets:
Cash and cash equivalents	$626,551	$482,047
Restricted cash	123,791	95,705
Accounts receivable, net of allowance for credit losses of $6,523 and $5,361	314,114	315,465
Contract assets, net of allowance for credit losses of $96 and $106	230,352	197,478
Inventories, net	34,594	33,728
Prepaid expenses and other current assets	59,878	69,994
Total current assets	1,389,280	1,194,417
Long-term investments	73,757	89,267
Property, plant, and equipment, net	472,663	479,109
Operating lease right-of-use assets	34,086	39,046
Intangible assets, net	412,059	434,514
Goodwill	525,024	533,208
Deferred taxes	223,410	219,758
Other non-current assets	98,757	120,609
Total assets	$3,229,036	$3,109,928
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$17,288	$17,380
Accrued liabilities	376,498	347,529
Income taxes payable	13,309	9,045
Contract liabilities	39,615	31,644
Operating lease liabilities	10,775	12,238
Total current liabilities	457,485	417,836
Non-current contract liabilities	29,664	34,593
Non-current operating lease liabilities	29,656	34,754
Other non-current liabilities	129,212	135,852
Total liabilities	646,017	623,035
Commitments and Contingencies (See Note 15)
Stockholders’ equity:
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 61,399,034 shares issued and outstanding as of March 28, 2025 and 59,722,442 as of September 27, 2024	55	53
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 34,660,604 shares issued and outstanding as of March 28, 2025 and 35,670,779 as of September 27, 2024	40	41
Retained earnings	2,601,552	2,496,255
Accumulated other comprehensive loss	(27,978)	(19,187)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,573,669	2,477,162
Noncontrolling interest	9,350	9,731
Total stockholders’ equity	2,583,019	2,486,893
Total liabilities and stockholders’ equity	$3,229,036	$3,109,928

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.